December 18, 2019 by Chain Drug Review
Consumer Healthcare Products Association (CHPA), National Institute on Drug Abuse (NIDA), Scott Melville
Leading Headlines
WASHINGTON — The 2019 results from the National Institute on Drug Abuse (NIDA) and University of Michigan’s annual drug abuse survey, Monitoring the Future, were released Wednesday showing that the number of teens using over-the-counter (O-T-C) cough medicine containing dextromethorphan (DXM) to get high decreased slightly, coming in at under 3%. When first reported in
December 4, 2019 by Chain Drug Review
Beth Allgaier, Scott Melville, The Consumer Healthcare Products Association (CHPA)
Leading Headlines
WASHINGTON – The Consumer Healthcare Products Association (CHPA) announced that Beth Allgaier has been named senior vice president, business development and industry relations. Allgaier will be responsible for the association’s membership, education, and meetings functions, in addition to serving as chief liaison to the retail community. She will be a member of the association’s senior
November 14, 2019 by Chain Drug Review
CBD (cannabidiol), FDA, Scott Melville, The Consumer Healthcare Products Association (CHPA)
Leading Headlines, Supplier News
WASHINGTON — The Consumer Healthcare Products Association (CHPA) submitted on Thursday a citizen petition to the U.S. Food and Drug Administration (FDA) urging the agency to exercise its existing statutory authority to swiftly issue regulations that establish a clear pathway for manufacturers to lawfully market cannabidiol (CBD) in dietary supplements. “Intense consumer demand and commercial interest
October 24, 2019 by Chain Drug Review
Consumer Healthcare Products Association (CHPA), Scott Melville
Leading Headlines, Pharmacy
WASHINGTON — The House Ways and Means Committee on Thursday took an important step toward reinstating consumers’ ability to purchase over-the-counter (O-T-C) medicines with tax-preferred savings accounts, including Flexible Spending Arrangements (FSAs) and Health Savings Accounts (HSAs). The Restoring Access to Medication Act (H.R. 1922), authored by Representatives Ron Kind (D, Wis.), Grace Meng (D
May 20, 2019 by Chain Drug Review
CHPA, Scott Melville
Leading Headlines, Pharmacy
WASHINGTON — On May 17th, Texas Governor Greg Abbott signed into law an age-18 requirement for the purchase of over-the-counter (O-T-C) medicines containing the cough suppressant dextromethorphan (DXM), an ingredient which is abused by some teenagers to get high. Texas is the 19thstate to prohibit the sale of O-T-C cough medicine to minors, joining other
March 19, 2019 by Chain Drug Review
2019 Annual Executive Conference, Scott Melville, The Consumer Healthcare Products Association (CHPA)
Leading Headlines, Supplier News
WASHINGTON – The Consumer Healthcare Products Association (CHPA) concluded their 2019 Annual Executive Conference, held from March 17-19, at the Boca Raton Resort and Club, in Boca Raton, Fla. More than 300 executives from the over-the-counter (OTC) drug, dietary supplement, and consumer medical device sectors heard from an impressive lineup of speakers, including renowned presidential historian and Pulitzer Prize-winning
December 17, 2018 by Chain Drug Review
Consumer Healthcare Products Association (CHPA), Fred Muench, Monitoring the Future, National Institute on Drug Abuse (NIDA), Scott Melville, teens using over-the-counter (O-T-C) cough medicine containing dextromethorphan (DXM) to get high, University of Michigan’s annual drug abuse survey
Leading Headlines, Pharmacy
WASHINGTON — The 2018 results from the National Institute on Drug Abuse (NIDA) and University of Michigan’s annual drug abuse survey, Monitoring the Future, were released today showing that the percentage of teens using over-the-counter (O-T-C) cough medicine containing dextromethorphan (DXM) to get high remains at 3 %. When first reported in 2006, the number of teens abusing O-T-C cough medicines
November 15, 2018 by Chain Drug Review
Consumer Healthcare Products Association (CHPA), Gary Downing, Patrick Lockwood-Taylor, Paul Gama, Scott Melville
Leading Headlines
WASHINGTON — New members of the Consumer Healthcare Products Association (CHPA) board of directors were elected at the association’s fall meeting, held November 14, in New York City. Gary Downing, chief executive officer, Clarion Brands, continues serving as CHPA’s board chairman. Newly elected CHPA board members at this meeting include: Paul Gama, vice president, North America
May 2, 2018 by Chain Drug Review
Consumer Healthcare Products Association (CHPA), Gary Downing, Scott Melville, The Food and Drug Administration’s O-T-C monograph system
Opinion
WASHINGTON — The stage is set for a regulatory change that will boost innovation by consumer health care products manufacturers, according to leaders of their association. The Food and Drug Administration’s O-T-C monograph system, which hasn’t been updated for over 45 years, is facing massive modernization efforts in the form of pending legislation in both
April 17, 2017 by Chain Drug Review
CHPA, Consumer Healthcare Products Association, Council for Responsible Nutrition, CRN, dietary supplement product label registry, Scott Melville, Steve Mister, Supplement Online Wellness Library, Supplement OWL, UL
Supplier News, Videos
WASHINGTON — The Consumer Healthcare Products Association (CHPA) has called on members that market dietary supplements to submit product labels to the Supplement Online Wellness Library (OWL) developed by Council for Responsible Nutrition (CRN) and independent safety science firm UL. CRN said the announcement follows talks between CHPA and its Dietary Supplements Committee, which reviewed
March 16, 2017 by Chain Drug Review
Andrew Mandzy, CHPA, Consumer Healthcare Products Association, Nielsen, OTC allergy medicines, Rx-to-OTC switches, Scott Melville
Leading Headlines, Pharmacy, Supplier News
WASHINGTON — More allergy sufferers are opting for over-the-counter medicines to alleviate their symptoms as more prescription products switch to OTC status, according to new research Consumer Healthcare Products Association (CHPA) and Nielsen. CHPA said Thursday the study found that 60% adult allergy sufferers use only OTCs for treatment, up from just more than half
January 18, 2017 by Scott Melville and Chain Drug Review
Affordable Care Act, CHPA, Consumer Healthcare Products Association, drug take-back programs, FSAs, HSAs, NPLEx, OTC medicines, over-the-counter medications, Restoring Access to Medication Act, Scott Melville
Leading Headlines, Opinion
The past year has brought much change, perhaps most evident in the recent national and local elections. As we welcome a new American president and Congress, the country is waiting to see how the regulatory and legislative landscape will evolve. But I am certain that one thing will not change: the continued importance of over-the-counter
May 2, 2016 by Chain Drug Review
CHPA, Consumer Healthcare Products Association, methamphetamine, National Precursor Log Exchange, NPLEx, PSE, pseudoephedrine, Scott Melville
Supplier News
WASHINGTON — The Consumer Healthcare Products Association (CHPA) has applauded Georgia for becoming the 33rd state to adopt real-time, stop-sale technology for illegal purchases of medication containing pseudoephedrine (PSE). Georgia Gov. Nathan Deal last week signed legislation, approved by the state legislature and sponsored by State Rep. David Clark Clark and State Sen. Renee Unterman (R.),
March 16, 2016 by Chain Drug Review
2016 CHPA Annual Executive Conference, CHPA, Consumer Healthcare Products Association, Jeffrey Needham, Patrick Lockwood-Taylor, Perrigo, Procter & Gamble, Scott Melville
Leading Headlines, Supplier News
WASHINGTON — The Consumer Healthcare Products Association (CHPA) has elected officers and members to its board of directors. CHPA said Wednesday that Patrick Lockwood-Taylor, vice president of Personal Health Care North America and Digestive Wellness Design for Procter & Gamble Co., will continue to serve as chairman. Jeffrey Needham, executive vice president and general manager